Summary
This 8-K/A filing from Abbott Laboratories serves as an amendment to a previous filing, clarifying an event that occurred on October 7, 2004. The primary disclosure pertains to the appointment of William M. Daley to two key committees of the Board of Directors: the Compensation Committee and the Public Policy Committee. This appointment follows Mr. Daley's initial naming to the Board of Directors, which was previously reported on October 15, 2004. Investors should note this as a governance update, indicating continued integration of new board members into significant committee roles. The amendment does not introduce new financial results or material changes to operational performance but rather refines the reporting of a board-level change. For investors, this highlights the company's attention to board composition and the strategic placement of directors with relevant expertise on committees that oversee executive compensation and corporate policy. The filing date of January 31, 2005, is for the amendment, while the original event dates back to October 2004.
Key Highlights
- 1Amendment to a previous 8-K filing by Abbott Laboratories.
- 2Event date of the original disclosure was October 7, 2004.
- 3William M. Daley appointed to the Compensation Committee of the Board of Directors.
- 4William M. Daley also appointed to the Public Policy Committee of the Board of Directors.
- 5Mr. Daley was previously appointed to the Board of Directors on October 8, 2004.
- 6This filing is a governance update, not a financial performance disclosure.
- 7The amendment was filed on January 31, 2005.